GlassScriptPhysician profile
Seth Jared Stofferahn
NPI 1790353159
$2,824.43
in general payments reported to CMS, 2019-2025
18 companies · $865 in 2025
The $865 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $460 · 2023: $433 · 2024: $792 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.95 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $572.93 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Mallinckrodt Hospital Products INC. | $475.02 | 2021-2025 | Acthar |
| Glaukos Corporation | $414.16 | 2022-2025 | Photrexa Viscous and Photrexa, Idosetr, Ce-Marked Kxla System |
| Sun Pharmaceutical Industries INC. | $235.78 | 2021-2025 | Cequa |
| Bausch & Lomb Americas INC. | $211.04 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $210.60 | 2022-2025 | Clareon, Hydrus Microstent, Acrysof Iq Panoptix Uv Iol |
| Tarsus Pharmaceuticals, INC. | $162.58 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $123.44 | 2022-2023 | Tyrvaya |
| Amgen INC. | $103.47 | 2024-2025 | Tepezza |
| Dompe US, INC. | $102.18 | 2022-2025 | Oxervate |
| Horizon Therapeutics Plc | $45.96 | 2022-2023 | Tepezza |
| Rxsight INC | $44.56 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Sight Sciences, INC. | $27.26 | 2021-2024 | Omni Surgical System |
| Harrow Eye, LLC | $23.80 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $22.25 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $18.10 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $16.24 | 2024 | Tecnis Iol |
| Biotissue Holdings INC. | $15.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Stofferahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.